Research Article
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
| | Events | Rivaroxaban | Warfarin | value | | () | () |
| | Major bleeding other than GI bleeding | 6 (4.08%) | 4 (2.61%) | 0.5348 | | ICH | 1 (0.68%) | 0 (0%) | 0.4900 | | Stroke or TIA | 1 (0.68%) | 1 (0.65%) | 1.0000 | | Symptomatic VTE | 2 (1.36%) | 2 (1.31%) | 1.0000 | | ACS that required interventions | 3 (2.04%) | 8 (5.23%) | 0.2189 | |
All-cause death | 2 (1.36%) | 8 (5.23%) | 0.1042 |
|
|
ACS: acute coronary syndrome, ICH: intracranial hemorrhage, TIA: transient ischemic attack, and VTE: venous thromboembolism events.
|
